Seminar 25 – Genome Editing with CRISPR Technology: applications and ethical considerations

Prof. Mazhar Adli
Northwestern University, USA.

2 May 2021 – 6:00pm (UTC)

Prof. Mazhar Adli is an associate Professor at Northwestern Medical School, Robert H Lurie Comprehensive cancer center, and the department of ObGyn. He obtained his Ph.D. from the University of North Carolina at Chapel Hill (NC, USA) in 2007. He completed his postdoctoral training from Harvard Medical School at the Broad Institute of Harvard and MIT in 2012.  

He started his independent laboratory at the University of Virginia, School of medicine, where he joined as an assistant professor and rose to the associate professor rank. Dr. Adli joined Feinberg School of medicine in January of 2020. His laboratory is developing cutting edge genome editing and manipulation tools to understand genome organization in healthy and disease settings. The Adli lab has strong expertise in epigenomic mapping and CRISPR-based genome and epigenome manipulation technologies. Our ultimate research goals in Adli lab are to understand key drivers of cancer progression and identify novel therapeutic drug combinations to cure cancer and prevent chemoresistance. To achieve this, his laboratory integrates experimental tools with large-scale computational data analysis approaches.